Social Media Ideas for Liquid Biopsy

Breakthrough Blood Test Paves the Way for Enhanced Cancer Care

Advancements in Cancer Detection: A Statistical Breakthrough Enables Monitoring of Tumors Using Minimal Circulating DNA Cancer detection and monitoring through blood tests, commonl...

Caris Life Sciences launches cancer blood test ‘Caris Detect’

Caris Life Sciences has launched a new oncology blood test designed alongside AI modelling to pick up cancer at earlier stages.

This compact Chinese device can detect cancer biomarkers in a drop of blood

A single drop of blood could soon be used to screen for early-stage cancer, according to Wen Liaoyong of Westlake University in Hangzhou. Wen’s team has compressed what was once a...

Promising ‘Liquid Biopsies’ May Not Be Ready for Primetime

Some experts say the tests, which can spot multiple kinds of cancer, aren’t yet sensitive enough to be widely used. The post Promising ‘Liquid Biopsies’ May Not Be Ready for Primet...

No more painful biopsies? How a new blood test will transform cancer detection in Hong Kong

In the fourth instalment of a six-part Health Matters wellness series on cancer in Hong Kong, Elizabeth Cheung examines how city researchers are developing new blood tests to detec...

Partnership with Oxford Nanopore Technologies will support development of RNA liquid biopsy for cancer early detection

RNA sequencing and nanopore sequencing enabled Eclipse-like full transcriptome analysis to identify novel non-coding RNA biomarkers in extracellular vesicles for early esophageal.....

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx.

Can a blood test tell if cancer is returning? Research is underway

If the test, also known as a liquid biopsy, is positive, those patients could get additional experimental treatments, to try to prevent the cancer coming back.

Novel nanowire device offers rapid, noninvasive cancer detection

The device selectively captured cancer biomarkers from the blood serum of ovarian cancer patients.

Predicta links with Spanish university to offer diagnostic for blood cancers

Predicta Biosciences, a precision oncology specialist, is teaming with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics clinic to offer an assay focused on blood cancers.

RNA sequencing of blood samples can monitor immune responses and help tailor treatment for high-risk patients.

RNA sequencing of blood samples may help predict immune response to chemoimmunotherapy and support more personalized treatment strategies for high-risk...

Freenome colorectal cancer test data improve on earlier results

The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analy...

Gold nanoparticle sensor detects early liver fibrosis without a tissue biopsy

Detects minute signals in a small blood sample, paving the way for early diagnosis of the disease that causes the liver to harden.

Can a blood test tell patients if their cancer is coming back? Researchers are on it

Researchers at Princess Margaret Cancer Centre are working on a trial to determine if a blood test can detect tiny amounts of cancer remaining after patients have been treated.  

Study Finds Lung Biopsy Cryoprobe Significantly Improves Diagnostic Accuracy Compared to Standard Forceps

A groundbreaking clinical trial has reshaped the landscape of interventional pulmonology by demonstrating a remarkable improvement in diagnostic accuracy when employing cryobiopsy...

Chimeric RNAs expand the potential of RNA sequencing for disease detection

RNA sequencing combined with the ChiTaRS platform improves detection of disease associated chimeric RNAs, supporting biomarker discovery, liquid biopsy, and precision medicine...

Blood test can predict lung cancer 5 years before diagnosis

Scientists found blood markers that can predict lung cancer more than five years in advance. This breakthrough could help detect the disease early in India, where most cases are fo...

A blood test that screens for multiple types of cancer? It may be available soon

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Saliva Test Links Oral Precancer to Clinical Outcomes

In the relentless pursuit to unravel the complexities of oral cancer development, a groundbreaking study led by Chen and colleagues has surfaced, shedding light on a novel biomarke...

Trial of early cancer detection test misses primary endpoint

CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.T...

Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?

While many drugmakers are focused on lung cancer, evidence shows the liver may be a better bet.

Study is first demonstration of gene transcription measurement in the living brain

A new blood-test platform enables noninvasive monitoring of gene expression in living tissues over time, complementing RNA sequencing approaches for studying disease progression......

A Blood Test Could One Day Detect Over 50 Types of Cancer — What That Means for Cancer Care

New tests claim to detect more than 50 types of cancer from a single blood sample, but more research is still needed. Discover more about it.

bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodul...